Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
203 studies found for:    "Myelitis"
Show Display Options
Rank Status Study
1 Terminated Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis
Condition: Transverse Myelitis
Interventions: Drug: Dalfampridine;   Drug: Placebo controlled
2 Recruiting Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study
Condition: Myelitis, Transverse
Intervention:
3 Active, not recruiting Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Conditions: Transverse Myelitis;   Neuromyelitis Optica;   Idiopathic Transverse Myelitis;   Myelitis NOS
Interventions: Drug: Dalfampridine;   Drug: Placebo
4 Terminated A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
Conditions: Myelitis, Transverse;   Neuromyelitis Optica
Interventions: Drug: Intravenous Methylprednisolone;   Drug: Intravenous Immunoglobulin
5 Active, not recruiting CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies
Condition: Inflammatory Myelopathies
Interventions: Device: FES Cycling;   Device: Cycling without FES;   Procedure: Lumbar puncture;   Behavioral: Mood assessment
6 Recruiting A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Transverse Myelitis;   Optic Neuritis
Intervention:
7 Completed Safety and Tolerability of Rituximab in Neuromyelitis Optica
Condition: Neuromyelitis Optica
Intervention: Drug: Rituximab
8 Recruiting Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
Intervention: Drug: Ublituximab
9 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
Intervention:
10 Active, not recruiting Maintenance Plasma Exchange for Neuromyelitis Optica
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
Intervention: Procedure: Plasma exchange (PLEX)
11 Unknown  Serum Auto-Antibodies
Conditions: Multiple Sclerosis;   Myasthenia Gravis;   Transverse Myelitis
Intervention: Other: Blood Draw
12 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Polygam® S/D;   Drug: Placebo
13 Completed Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
14 Completed
Has Results
Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
Intervention: Drug: Bevacizumab
15 Completed A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)
Conditions: Neuromyelitis Optica;   Myelitis, Transverse;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System
Intervention: Drug: Mitoxantrone
16 Withdrawn Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
Conditions: Demyelinating Disorders;   Multiple Sclerosis;   Optic Neuritis;   Myelitis;   Neuritis
Interventions: Drug: interferon beta 1a;   Drug: methotrexate;   Drug: methylprednisolone
17 Active, not recruiting Biobank For MS And Other Demyelinating Diseases
Conditions: Multiple Sclerosis;   Transverse Myelitis;   Neuromyelitis Optica;   Acute Disseminated Encephalomyelitis;   Optic Neuritis
Intervention:
18 Unknown  Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Conditions: Acute Disseminated Encephalomyelitis;   Devic's Syndrome;   Marburg's Variant of Multiple Sclerosis;   Balo's Concentric Sclerosis;   Acute Transverse Myelitis
Intervention: Procedure: Plasma exchange
19 Recruiting Clinical Trial of a Serious Game for Individuals With SCI/D
Conditions: Spinal Cord Injury;   Spinal Cord Involvement;   Spina Bifida;   Transverse Myelitis;   Polio and Post-polio Syndrome;   Syringomyelia;   Spinal Stenosis;   Spinal Neoplasms;   Spinal Cord Diseases
Intervention: Behavioral: SCI Hard
20 Unknown  Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses
Condition: Neuromyelitis Optica
Interventions: Drug: Alpha1-antitrypsin;   Drug: methylprednisolone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.